Unleashing the power of omics-driven liquid biopsy in anti-cancer drug resistance: From biomarker discovery to clinical translation
Integrated Diagnostics · 2026-12 · 1 (1) · 100003
DOI: 10.1016/j.intdia.2026.100003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrated Diagnostics, 2026-12. Verfasst von Bohan Zhang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, B., Dong, L., Gao, J., Yuan, L., Wang, W., Zhou, Z., Wang, N., & Chen, Z. (2026). Unleashing the power of omics-driven liquid biopsy in anti-cancer drug resistance: From biomarker discovery to clinical translation. Integrated Diagnostics, 1(1), 100003. https://doi.org/10.1016/j.intdia.2026.100003
Vancouver
Zhang B, Dong L, Gao J, Yuan L, Wang W, Zhou Z, et al. Unleashing the power of omics-driven liquid biopsy in anti-cancer drug resistance: From biomarker discovery to clinical translation. Integrated Diagnostics. 2026;1(1):100003. doi:10.1016/j.intdia.2026.100003
BibTeX
@article{Zhang2026,
author = {Zhang, Bohan and Dong, Lianghui and Gao, Junshun and Yuan, Luoxi and Wang, Weixin and Zhou, Zhuxian and Wang, Nan and Chen, Zhe-Sheng},
title = {Unleashing the power of omics-driven liquid biopsy in anti-cancer drug resistance: From biomarker discovery to clinical translation},
journal = {Integrated Diagnostics},
year = {2026},
volume = {1},
number = {1},
pages = {100003},
doi = {10.1016/j.intdia.2026.100003}
}
EUVIMED